Polymorphisms in the CTLA‐4 gene and inhibitor development in patients with severe hemophilia A

This publication has 14 references indexed in Scilit:

• Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia
  Haemophilia, 2006
• Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A
  Blood, 2006
• Haemophilia Inhibitor Genetics Study – evaluation of a model for studies of complex diseases using linkage and association methods
  Haemophilia, 2005
• A CTLA-4 gene polymorphism at position −318 in the promoter region affects the expression of protein
  Genes & Immunity, 2002
• Association of CTLA‐4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population
  Rheumatology, 2001
• CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms
  Genes & Immunity, 2001
• CTLA-4 Gene Polymorphism at Position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves’ Disease
  The Journal of Immunology, 2000
• Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups
  Human Molecular Genetics, 1997
• An Mse I RFLP in the Human CTLA4 Promotor
  Biochemical and Biophysical Research Communications, 1996
• Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
  Science, 1995